Unlike other amino acids that primarily serve as building blocks, leucine functions as both a substrate and a signal, telling muscle cells to begin the growth and repair process
Last week, Novo Nordisk announced results from another clinical trial that found that Ozempic slowed the progression of kidney disease in patients with Type 2 diabetes
Orally disintegrating tablets represent another delivery pathway, though injectable remains the gold standard for consistent pharmacokinetics
I=41.8%), and 5 mg (MD: 20.3
However, the oral form has fewer long-term trials than the injectable version, which has been on the market for 14 years
Another limitation of GLP-1 RAs is that discontinuation commonly leads to substantial body weight regain, and many patients who regain weight subsequently restart GLP-1 RA therapy, resulting in a recurrent cycle of body weight loss and gain [10]